Behavioral Neurobiology of Schizophrenia and Its Treatment

Schizophrenia research is in a dynamic state; this text gives a foothold for where we stand today, and a map for where our field may move tomorrow. Chapters on treatment describe major changes in clinical and neural targets, and new technologies for drug delivery, even as we struggle to address adve...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
Άλλοι συγγραφείς: Swerdlow, Neal R. (Επιμελητής έκδοσης)
Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
Γλώσσα:English
Έκδοση: Berlin, Heidelberg : Springer Berlin Heidelberg : Imprint: Springer, 2010.
Σειρά:Current Topics in Behavioral Neurosciences, 4
Θέματα:
Διαθέσιμο Online:Full Text via HEAL-Link
LEADER 04491nam a22005535i 4500
001 978-3-642-13717-4
003 DE-He213
005 20151204164856.0
007 cr nn 008mamaa
008 100825s2010 gw | s |||| 0|eng d
020 |a 9783642137174  |9 978-3-642-13717-4 
024 7 |a 10.1007/978-3-642-13717-4  |2 doi 
040 |d GrThAP 
050 4 |a RC321-580 
072 7 |a PSAN  |2 bicssc 
072 7 |a MED057000  |2 bisacsh 
082 0 4 |a 612.8  |2 23 
245 1 0 |a Behavioral Neurobiology of Schizophrenia and Its Treatment  |h [electronic resource] /  |c edited by Neal R. Swerdlow. 
264 1 |a Berlin, Heidelberg :  |b Springer Berlin Heidelberg :  |b Imprint: Springer,  |c 2010. 
300 |a XVIII, 666 p. 47 illus., 18 illus. in color.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
490 1 |a Current Topics in Behavioral Neurosciences,  |x 1866-3370 ;  |v 4 
505 0 |a Assessing Function and Functional Outcome in Schizophrenia -- Antipsychotics and Metabolics in the Post-CATIE Era -- Pharmacological Strategies for Enhancing Cognition in Schizophrenia -- Treatment Implications of the Schizophrenia Prodrome -- Antipsychotic Drug Development -- Antipsychotic Dosing and Drug Delivery -- Functional Brain Imaging in Schizophrenia: Selected Results and Methods -- Neurochemical Imaging in Schizophrenia -- A Selective Review of Volumetric and Morphometric Imaging in Schizophrenia -- Neurophysiological Measures of Sensory Registration, Stimulus Discrimination, and Selection in Schizophrenia Patients -- Eye Tracking Dysfunction in Schizophrenia: Characterization and Pathophysiology -- Prepulse Inhibition of the Startle Reflex: A Window on the Brain in Schizophrenia -- Neurocognition in Schizophrenia -- Animal Models of Schizophrenia -- Models of Neurodevelopmental Abnormalities in Schizophrenia -- Prefrontal Cortical Circuits in Schizophrenia -- Thalamic Pathology in Schizophrenia -- Hippocampal Pathology in Schizophrenia -- Integrative Circuit Models and Their Implications for the Pathophysiologies and Treatments of the Schizophrenias -- Experimental Approaches for Identifying Schizophrenia Risk Genes -- Epigenetics of Schizophrenia -- Molecules, Signaling, and Schizophrenia. 
520 |a Schizophrenia research is in a dynamic state; this text gives a foothold for where we stand today, and a map for where our field may move tomorrow. Chapters on treatment describe major changes in clinical and neural targets, and new technologies for drug delivery, even as we struggle to address adverse effects of old treatments. The text next reviews advances in the experimental analysis of the schizophrenias. Where we once faced a paucity of biological signals, our field now sees an expanding list of clear neural abnormalities, and chapters focus on those in circuitry connecting prefrontal cortex, thalamus and mesial temporal lobes. The rapid evolution of schizophrenia genetics is described: older strategies for finding disorder genes, jettisoned in favor of studies of aberrant copy number variants, rare mutations or DNA methylation, and of molecular signaling pathways that trigger downstream disturbances in critical brain circuits. With what we now know about the complex biology of the schizophrenias, a key question becomes whether we can manipulate this biology in a way that fundamentally changes the course of this disorder. This text provides a context for students, investigators and clinicians to understand this stage in our evolving field, and to look ahead to the future of schizophrenia research. 
650 0 |a Medicine. 
650 0 |a Neurosciences. 
650 0 |a Neurochemistry. 
650 0 |a Pharmacology. 
650 0 |a Neurology. 
650 0 |a Psychiatry. 
650 0 |a Psychopharmacology. 
650 1 4 |a Biomedicine. 
650 2 4 |a Neurosciences. 
650 2 4 |a Pharmacology/Toxicology. 
650 2 4 |a Psychiatry. 
650 2 4 |a Psychopharmacology. 
650 2 4 |a Neurochemistry. 
650 2 4 |a Neurology. 
700 1 |a Swerdlow, Neal R.  |e editor. 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer eBooks 
776 0 8 |i Printed edition:  |z 9783642137167 
830 0 |a Current Topics in Behavioral Neurosciences,  |x 1866-3370 ;  |v 4 
856 4 0 |u http://dx.doi.org/10.1007/978-3-642-13717-4  |z Full Text via HEAL-Link 
912 |a ZDB-2-SBL 
950 |a Biomedical and Life Sciences (Springer-11642)